IL2 fused to lectin-deficient ricin is toxic to human leukemia cells expressing the IL2 receptor

A. E. Frankel, T. Fu, C. Burbage, J. Chandler, M. C. Willingham, E. P. Tagge

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Interleukin-2 (IL2) fused to ricin B chain (RTB) with modifications of amino acid residues in each of three galactose-binding subdomains (1α, 1β and 2γ) was expressed in insect cells, purified by immunoaffinity chromatography and reassociated with ricin A chain (RTA). The fusion toxin-bound human leukemic cells with IL2 receptors and the binding was competed with IL2 but not asialofetuin. In contrast, binding was not observed with receptor negative human cell lines, and the fusion molecule very weakly bound asialofetuin (K(d) = 10-6 M), indicating lectin-deficient RTB. The IL2-lectin-deficient RTB-RTA intoxicated IL2 receptor bearing cells as well as ricin or IL2-wild-type RTB-RTA. While ricin and IL2-wild-type RTB-RTA were equally toxic to receptor negative cell lines, the IL2-lectin-deficient RTB-RTA was two-two and one half logs less cytotoxic to these cell lines. The sensitivity of receptor-positive cells to the lectin-deficient fusion protein suggests that high avidity intracellular galactose binding may not be required for ricin intoxication, at least in the case of IL2 receptor-targeted molecules. Furthermore, the potent selective cytotoxicity of the fusion protein suggests that the IL2-lectin-deficient RTB-RTA and similar ricin fusion molecules directed against other leukemic cell surface receptors provide a novel class of fusion toxins for therapy of human leukemias.

Original languageEnglish (US)
Pages (from-to)22-30
Number of pages9
JournalLeukemia
Volume11
Issue number1
StatePublished - 1997

Fingerprint

Ricin
Interleukin-2 Receptors
Poisons
Lectins
Interleukin-2
Leukemia
Galactose
Cell Line
Cell Fusion
Cell Surface Receptors
Insects
Chromatography
Proteins
Amino Acids

Keywords

  • Fusion toxin
  • IL2 receptor
  • Ricin

ASJC Scopus subject areas

  • Hematology
  • Cancer Research

Cite this

Frankel, A. E., Fu, T., Burbage, C., Chandler, J., Willingham, M. C., & Tagge, E. P. (1997). IL2 fused to lectin-deficient ricin is toxic to human leukemia cells expressing the IL2 receptor. Leukemia, 11(1), 22-30.

IL2 fused to lectin-deficient ricin is toxic to human leukemia cells expressing the IL2 receptor. / Frankel, A. E.; Fu, T.; Burbage, C.; Chandler, J.; Willingham, M. C.; Tagge, E. P.

In: Leukemia, Vol. 11, No. 1, 1997, p. 22-30.

Research output: Contribution to journalArticle

Frankel, AE, Fu, T, Burbage, C, Chandler, J, Willingham, MC & Tagge, EP 1997, 'IL2 fused to lectin-deficient ricin is toxic to human leukemia cells expressing the IL2 receptor', Leukemia, vol. 11, no. 1, pp. 22-30.
Frankel AE, Fu T, Burbage C, Chandler J, Willingham MC, Tagge EP. IL2 fused to lectin-deficient ricin is toxic to human leukemia cells expressing the IL2 receptor. Leukemia. 1997;11(1):22-30.
Frankel, A. E. ; Fu, T. ; Burbage, C. ; Chandler, J. ; Willingham, M. C. ; Tagge, E. P. / IL2 fused to lectin-deficient ricin is toxic to human leukemia cells expressing the IL2 receptor. In: Leukemia. 1997 ; Vol. 11, No. 1. pp. 22-30.
@article{62b3099dbde6445ba87261bf8c21ba55,
title = "IL2 fused to lectin-deficient ricin is toxic to human leukemia cells expressing the IL2 receptor",
abstract = "Interleukin-2 (IL2) fused to ricin B chain (RTB) with modifications of amino acid residues in each of three galactose-binding subdomains (1α, 1β and 2γ) was expressed in insect cells, purified by immunoaffinity chromatography and reassociated with ricin A chain (RTA). The fusion toxin-bound human leukemic cells with IL2 receptors and the binding was competed with IL2 but not asialofetuin. In contrast, binding was not observed with receptor negative human cell lines, and the fusion molecule very weakly bound asialofetuin (K(d) = 10-6 M), indicating lectin-deficient RTB. The IL2-lectin-deficient RTB-RTA intoxicated IL2 receptor bearing cells as well as ricin or IL2-wild-type RTB-RTA. While ricin and IL2-wild-type RTB-RTA were equally toxic to receptor negative cell lines, the IL2-lectin-deficient RTB-RTA was two-two and one half logs less cytotoxic to these cell lines. The sensitivity of receptor-positive cells to the lectin-deficient fusion protein suggests that high avidity intracellular galactose binding may not be required for ricin intoxication, at least in the case of IL2 receptor-targeted molecules. Furthermore, the potent selective cytotoxicity of the fusion protein suggests that the IL2-lectin-deficient RTB-RTA and similar ricin fusion molecules directed against other leukemic cell surface receptors provide a novel class of fusion toxins for therapy of human leukemias.",
keywords = "Fusion toxin, IL2 receptor, Ricin",
author = "Frankel, {A. E.} and T. Fu and C. Burbage and J. Chandler and Willingham, {M. C.} and Tagge, {E. P.}",
year = "1997",
language = "English (US)",
volume = "11",
pages = "22--30",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - IL2 fused to lectin-deficient ricin is toxic to human leukemia cells expressing the IL2 receptor

AU - Frankel, A. E.

AU - Fu, T.

AU - Burbage, C.

AU - Chandler, J.

AU - Willingham, M. C.

AU - Tagge, E. P.

PY - 1997

Y1 - 1997

N2 - Interleukin-2 (IL2) fused to ricin B chain (RTB) with modifications of amino acid residues in each of three galactose-binding subdomains (1α, 1β and 2γ) was expressed in insect cells, purified by immunoaffinity chromatography and reassociated with ricin A chain (RTA). The fusion toxin-bound human leukemic cells with IL2 receptors and the binding was competed with IL2 but not asialofetuin. In contrast, binding was not observed with receptor negative human cell lines, and the fusion molecule very weakly bound asialofetuin (K(d) = 10-6 M), indicating lectin-deficient RTB. The IL2-lectin-deficient RTB-RTA intoxicated IL2 receptor bearing cells as well as ricin or IL2-wild-type RTB-RTA. While ricin and IL2-wild-type RTB-RTA were equally toxic to receptor negative cell lines, the IL2-lectin-deficient RTB-RTA was two-two and one half logs less cytotoxic to these cell lines. The sensitivity of receptor-positive cells to the lectin-deficient fusion protein suggests that high avidity intracellular galactose binding may not be required for ricin intoxication, at least in the case of IL2 receptor-targeted molecules. Furthermore, the potent selective cytotoxicity of the fusion protein suggests that the IL2-lectin-deficient RTB-RTA and similar ricin fusion molecules directed against other leukemic cell surface receptors provide a novel class of fusion toxins for therapy of human leukemias.

AB - Interleukin-2 (IL2) fused to ricin B chain (RTB) with modifications of amino acid residues in each of three galactose-binding subdomains (1α, 1β and 2γ) was expressed in insect cells, purified by immunoaffinity chromatography and reassociated with ricin A chain (RTA). The fusion toxin-bound human leukemic cells with IL2 receptors and the binding was competed with IL2 but not asialofetuin. In contrast, binding was not observed with receptor negative human cell lines, and the fusion molecule very weakly bound asialofetuin (K(d) = 10-6 M), indicating lectin-deficient RTB. The IL2-lectin-deficient RTB-RTA intoxicated IL2 receptor bearing cells as well as ricin or IL2-wild-type RTB-RTA. While ricin and IL2-wild-type RTB-RTA were equally toxic to receptor negative cell lines, the IL2-lectin-deficient RTB-RTA was two-two and one half logs less cytotoxic to these cell lines. The sensitivity of receptor-positive cells to the lectin-deficient fusion protein suggests that high avidity intracellular galactose binding may not be required for ricin intoxication, at least in the case of IL2 receptor-targeted molecules. Furthermore, the potent selective cytotoxicity of the fusion protein suggests that the IL2-lectin-deficient RTB-RTA and similar ricin fusion molecules directed against other leukemic cell surface receptors provide a novel class of fusion toxins for therapy of human leukemias.

KW - Fusion toxin

KW - IL2 receptor

KW - Ricin

UR - http://www.scopus.com/inward/record.url?scp=0031056677&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031056677&partnerID=8YFLogxK

M3 - Article

C2 - 9001414

AN - SCOPUS:0031056677

VL - 11

SP - 22

EP - 30

JO - Leukemia

JF - Leukemia

SN - 0887-6924

IS - 1

ER -